5/10/2024
Novavax Soars on Major Sanofi Partnership, Opening New Doors for Biotech Investors
In a dramatic turn of events, shares of Novavax skyrocketed over 130% on Friday after the struggling vaccine maker announced a landmark deal with global pharmaceutical giant Sanofi. This multibillion-dollar agreement could prove to be a game-changer, not just for Novavax’s outlook, but for biotech investors evaluating the emerging opportunities across the vaccine technology landscape.
0
4 min read